The drug company also pays “legalized bribes” to the PI grantee through honoraria, expert witness fees, speaking gigs, and first-class travel to exclusive resorts for conferences. All these perquisites tend to fortify loyalty and incentivize the favorable research results necessary to securing FDA drug approvals. On all sides of these transactions, each stakeholder understands that positive reviews of the subject drug promise future work.
